Acreage Holdings Reports Second Quarter 2022 Financial Results

Acreage Holdings, Inc.

Marked 6^th consecutive quarter of positive Adjusted EBITDA^* with sequential improvement of 20% quarter-over-quarter

Continued solid revenue growth with a 39% increase year-over-year and an 8% increase quarter-over-quarter to $61.4 million for Q2 2022

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today reported its financial results for the second quarter ended June 30, 2022 (“Q2 2022”).

Second Quarter 2022 Financial Highlights

• Consolidated revenue was $61.4 million for Q2 2022, an increase of 39% year-over-year.

• Gross margin of 50% compared to 52% in Q1 2022, and 54% in Q2 2021.

• Adjusted EBITDA* was $10.4 million in Q2 2022, compared to $8.1 million in Q2 2021, and $8.6 million in Q1 2022. Adjusted EBITDA* as a percentage of consolidated revenue was 16.9% for the second quarter of 2022.
  

Second Quarter 2022 Operational Highlights

• One of an inaugural group of cannabis operators to commence adult-use operations in New Jersey, with various products from The Botanist now available to adult-use consumers at the Company’s Egg Harbor Township and Williamstown dispensaries in southern New Jersey.

• Completed the first phase of expansion on the Company’s cultivation facility in Syracuse, New York, positioning Acreage to further support wholesale demand in the existing medical market in addition to preparing for the impending launch of adult-use sales.

• Completed the sale of the Company’s cultivation and processing facility in Medford, Oregon, for total consideration of $2.0 million, and closed its dispensary in Powell, Oregon.

• Strengthened operations with the consolidation and conversion of the Company’s dispensary in Brewer, Maine, to adult-use.

Subsequent Events

• Launched the sale of whole flower in New York under the state’s strict microbial testing regulations, making Acreage one of the only producers in the state with the capability to supply non-remediated whole flower to the market.

• Concluded operations in Oregon with the completion of the sale of the Company’s four Oregon retail dispensaries branded as Cannabliss & Co.

Management Commentary

“We were thrilled to execute on a significant milestone with the launch of adult-use sales in the state of New Jersey during the second quarter,” said Peter Caldini, CEO of Acreage. “The initial performance of our retail stores during the roll-out has been strong, and we believe there is an even bigger opportunity to further optimize our cultivation and wholesale capabilities to serve this growing market. We are working diligently to improve our New Jersey cultivation and processing operations to take advantage of the market opportunities that are available to us.”

Mr. Caldini continued, “With the additional contributions from New Jersey, as well as our recently acquired operations in Ohio, we saw overall revenue growth of 39%, which has led to our sixth consecutive quarter of positive Adjusted EBITDA. This track record of success continues to demonstrate the strong impact our disciplined strategy has had on both our financial and operating performance.”

Mr. Caldini concluded, “With the conclusion of our operations in Oregon following the end of the quarter, we are in a more favorable position to drive development in our core markets, where we see the best opportunity to foster long-term growth and enhance shareholder value. During the latter half of the year, we will continue our preparation for pending adult-use sales in these developing Northeastern markets, such as New York and Connecticut, in addition to strengthening our presence in New Jersey."

Q2 2022 Financial Summary
(in thousands)

	Three Months Ended June 30,								YoY% Change		Three Months Ended March 31, 2022				QoQ% Change
		2022				2021
Consolidated Revenue	$	61,351			$	44,217			39%		$	56,879			8%
Gross Profit		30,614				23,875			28%			29,510			4%
% of revenue		50%				54%						52%
Total operating expenses		27,304				30,632			(11)%			32,232			(15)%
Net loss		(10,603	)			(3,306	)					(13,911	)
Net loss attributable to Acreage		(9,929	)			(2,553	)					(12,694	)
Adjusted EBITDA*		10,385				8,086			28%			8,627			20%

Total revenue for Q2 2022 was $61.4 million, an increase of $17.1 million or 39% compared to Q2 2021. The year-over-year growth was primarily driven by the acquisition of operations in Ohio as well as the commencement of adult-use sales in New Jersey, which was somewhat offset by declines within the Company’s operations that were held for sale. Additionally, total revenue for Q2 2022 improved sequentially by $4.5 million or 8% compared to the first quarter. Excluding the Company’s Oregon operations. which are not considered core, however, revenue for the three months ended June 30, 2022, increased by 9% on a sequential basis as the Company was able to overcome challenges associated with industry pricing pressures which negatively impacted revenues.        

Total gross profit for Q2 2022 was $30.6 million, an increase of $6.7 million or 28% compared to Q2 2021, driven by an increase in revenue. Total gross margin was 50% in Q2 2022 compared to 54% in the second quarter of 2021, as efficiencies gained from further economies of scale were unable to offset overall selling price declines and cost increases due to inflation.

Total operating expenses for Q2 2022 decreased by $3.3 million, or 11%, to $27.3 million, from Q2 2021. Increases in compensation and general and administrative expenses were more than offset by reductions in equity-based compensation expense, losses on notes receivable and depreciation and amortization expenses.

Adjusted EBITDA* for the second quarter of 2022 increased to $10.4 million, a 28% improvement compared to Adjusted EBITDA* of $8.1 million in the second quarter of 2021 and a 20% improvement from Adjusted EBITDA* of $8.6 million in the first quarter of 2022. Adjusted EBITDA from core operations*, which excludes markets where Acreage has entered into definitive agreements to exit and start-up ventures such as beverages and CBD, was $10.9 million, indicating the Company's core markets are still being negatively impacted by its non-core operations. Consolidated EBITDA* for the second quarter of 2022 was $7.1 million, compared to a consolidated EBITDA* of $6.7 million in the previous year's comparable period.

Net loss attributable to Acreage for Q2 2022 was $(9.9) million, compared to $(2.5) million in the second quarter of 2021.

Balance Sheet and Liquidity

Acreage ended the quarter with $29.3 million in cash and cash equivalents. As of June 30, 2022, $100.0 million was drawn under the Credit Facility entered in the fourth quarter of 2021. A further $50.0 million is available in future periods under a committed accordion option once certain, predetermined milestones are achieved. Acreage intends to use the proceeds of the Credit Facility to fund expansion initiatives, repay existing debt, and provide additional working capital.        

Earnings Call
Management will host a conference call on August 9, 2022, at 10:00 a.m. ET to discuss the results in detail.

Webcast:	Click here
Dial-in:	Canada - 1-833-950-0062 (toll-free) or 1-226-828-7575 US - 1-844-200-6205 (toll-free) or 1-646-904-5544 International - +1-929-526-1599
Conference ID:	625586

The webcast will be archived and can be accessed via Acreage’s website at investors.acreageholdings.com.

About Acreage Holdings, Inc.

Acreage is a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., including the Company’s national retail store ‎brand, The Botanist. With its principal address in New York City, Acreage’s wide range of national and regionally available cannabis products include the award-winning The Botanist brand, craft brand Superflux, the Tweed brand, the Prime medical brand in Pennsylvania, the Innocent brand in Illinois and others. Acreage also owns Universal Hemp, LLC, a hemp subsidiary dedicated to the distribution, marketing and sale of CBD products throughout the U.S. Since its founding in 2011, Acreage has focused on building and scaling operations to create a seamless, consumer-focused, branded experience. Learn more at www.acreageholdings.com and follow us on Twitter, LinkedIn, Instagram, and Facebook.

Forward Looking Statements

This news release and each of the documents referred to herein contains “forward-looking information” and ‎‎“forward-looking statements” within the meaning of applicable Canadian and United States securities legislation, ‎respectively. All statements, other than statements of historical fact, included herein are forward-looking ‎information. ‎Often, but not always, forward-looking statements and information can be identified by the use of words such as ‎‎“plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, ‎or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, ‎‎‎“would”, “might” or “will” be taken, occur or be achieved. ‎

Forward-looking statements or information involve known and unknown risks, uncertainties, and other ‎factors which may cause the actual results, performance or achievements of Acreage or its ‎subsidiaries to be materially different from any future results, performance or achievements expressed or ‎implied by the forward-looking statements or information contained in this news release. Risks, uncertainties and other factors involved with forward-looking ‎information could cause actual events, results, performance, prospects and opportunities to differ ‎materially from those expressed or implied by such forward-looking information, including, but not ‎limited to financing and liquidity risks, and the risks disclosed in the Company’s Annual Report on Form 10-K for the year ended ‎December 31, 2021, ‎dated March 11, 2022 and the Company’s other public filings, in each case filed with the SEC on the EDGAR website at www.sec.gov and with ‎Canadian securities regulators ‎and available on the issuer profile of Acreage on SEDAR at www.sedar.com. Although Acreage has attempted to identify ‎important factors that could cause actual results to differ materially from those contained in forward-looking ‎information, there may be other factors that cause results not to be as anticipated, estimated or intended. ‎

Although Acreage believes that the ‎assumptions and factors used in preparing the forward-looking information or forward-looking ‎statements in this news release are reasonable, undue reliance should not be placed on such information ‎and no assurance can be given that such events will occur in the disclosed time frames or at all. The ‎forward-looking information and forward-looking statements included in this news release are made as of ‎the date of this news release and Acreage does not undertake any obligation to publicly update such ‎forward-looking information or forward-looking statements to reflect new information, subsequent events ‎or otherwise unless required by applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed and does not accept ‎responsibility for the adequacy or accuracy of the content of this news release.‎

For more information, contact:

Steve Goertz
Chief Financial Officer
investors@acreageholdings.com

Courtney Van Alstyne
MATTIO Communications
ir@mattio.com

US GAAP FINANCIAL HIGHLIGHTS (UNAUDITED)

US GAAP Statements of Financial Position
US$ (thousands)	June 30, 2022				December 31, 2021
	(unaudited)				(audited)
ASSETS
Cash and cash equivalents	$	29,235			$	43,180
Restricted cash		95				1,098
Accounts receivable, net		8,991				8,202
Inventory		52,553				41,804
Notes receivable, current		4,508				7,104
Short-term investments		3,403				—
Assets held-for-sale		3,905				8,952
Other current assets		3,417				2,639
Total current assets		106,107				112,979
Long-term investments		34,672				35,226
Notes receivable, non-current		26,242				27,563
Capital assets, net		138,697				126,797
Operating lease right-of-use assets		21,258				24,598
Intangible assets, net		119,303				119,695
Goodwill		43,534				43,310
Other non-current assets		3,379				1,383
Total non-current assets		387,085				378,572
TOTAL ASSETS	$	493,192			$	491,551
LIABILITIES AND MEMBERS’ EQUITY
Accounts payable and accrued liabilities	$	23,908			$	23,861
Taxes payable		21,326				24,572
Interest payable		3,454				1,432
Operating lease liability, current		2,244				2,145
Debt, current		7,363				1,583
Non-refundable deposits on sale		250				1,000
Liabilities related to assets held for sale		1,324				1,867
Other current liabilities		10,844				10,333
Total current liabilities		70,713				66,793
Debt, non-current		194,177				169,151
Operating lease liability, non-current		20,801				24,255
Deferred tax liability		26,215				27,082
Other liabilities		1,250				—
Total non-current liabilities		242,443				220,488
TOTAL LIABILITIES		313,156				287,281
Members' equity		175,939				197,267
Non-controlling interests		4,097				7,003
TOTAL MEMBERS’ EQUITY		180,036				204,270
TOTAL LIABILITIES AND MEMBERS' EQUITY	$	493,192			$	491,551

US GAAP FINANCIAL HIGHLIGHTS (UNAUDITED)

US GAAP Statements of Operations
US$ (thousands)	Q2'22				Q2'21				YTD'22				YTD'21
Retail revenue, net	$	46,685			$	28,396			$	88,112			$	54,243
Wholesale revenue, net		14,360				15,541				29,532				25,557
Other revenue, net		306				280				586				2,810
Total revenues, net		61,351				44,217				118,230				82,610
Cost of goods sold, retail		(23,466	)			(14,051	)			(44,234	)			(27,133	)
Cost of goods sold, wholesale		(7,271	)			(6,291	)			(13,872	)			(10,980	)
Total cost of goods sold		(30,737	)			(20,342	)			(58,106	)			(38,113	)
Gross profit		30,614				23,875				60,124				44,497
OPERATING EXPENSES
General and administrative		8,922				5,384				17,309				14,602
Compensation expense		12,579				11,175				26,774				21,537
Equity-based compensation expense		1,655				6,981				5,814				13,023
Marketing		964				397				1,661				409
Impairments, net		329				—				2,467				818
Loss on notes receivable		—				1,726				—				1,726
Write down (recovery) of assets held-for-sale		—				—				874				(8,616	)
Loss on legal settlements		(310	)			312				(335	)			322
Depreciation and amortization		3,165				4,657				4,972				5,626
Total operating expenses		27,304				30,632				59,536				49,447
Net operating income (loss)		3,310				(6,757	)			588				(4,950	)
Income (loss) from investments, net		(996	)			(1,122	)			137				(1,266	)
Interest income from loans receivable		365				1,593				782				3,058
Interest expense		(5,520	)			(5,595	)			(10,301	)			(10,452	)
Other loss, net		286				9,311				276				7,745
Total other loss		(5,865	)			4,187				(9,106	)			(915	)
Loss before income taxes		(2,555	)			(2,570	)			(8,518	)			(5,865	)
Income tax expense		(8,048	)			(736	)			(15,996	)			(6,082	)
Net loss		(10,603	)			(3,306	)			(24,514	)			(11,947	)
Less: net loss attributable to non-controlling interests		(674	)			(753	)			(1,891	)			(1,586	)
Net loss attributable to Acreage Holdings, Inc.	$	(9,929	)		$	(2,553	)		$	(22,623	)		$	(10,361	)
Net loss per share attributable to Acreage Holdings, Inc. - basic and diluted:	$	(0.09	)		$	(0.02	)		$	(0.21	)		$	(0.10	)
Weighted average shares outstanding - basic and diluted		108,230				104,853				107,569				103,605

*NON-GAAP MEASURES, RECONCILIATION AND DISCUSSION (UNAUDITED)

This release includes Adjusted EBITDA, which is a non-GAAP performance measure that we use to supplement our results presented in accordance with U.S. GAAP. The Company uses Adjusted EBITDA to evaluate its actual operating performance and for planning and forecasting future periods. The Company believes that the adjusted results presented provide relevant and useful information for investors because they clarify the Company’s actual operating performance, make it easier to compare our results with those of other companies and allow investors to review performance in the same way as our management. Since these measures are not calculated in accordance with U.S. GAAP, they should not be considered in isolation of, or as a substitute for, net loss or our other reported results of operations as reported under U.S. GAAP as indicators of our performance, and they may not be comparable to similarly named measures from other companies.

The Company defines Adjusted EBITDA as net income before interest, income taxes and, depreciation and amortization and excluding the following: (i) income from investments, net (the majority of the Company's investment income relates to remeasurement to fair value of previously-held interests in connection with our roll-up of affiliates, and the Company expects income from investments to be a non-recurring item as its legacy investment holdings diminish), (ii) equity-based compensation expense, (iii) non-cash impairment losses, (iv) transaction costs and (v) other non-recurring expenses (other expenses and income not expected to recur).

Reconciliation of GAAP to Non-GAAP Measures
US$ (thousands, except per share amounts)	Q2'22				Q2'21				YTD'22				YTD'21
Net loss (GAAP)	$	(10,603	)		$	(3,306	)		$	(24,514	)		$	(11,947	)
Income tax expense		8,048				736				15,996				6,082
Interest expense (income), net		5,155				4,002				9,519				7,394
Depreciation and amortization		4,456				5,272				7,347				6,794
EBITDA (non-GAAP)*	$	7,056			$	6,704			$	8,348			$	8,323
Adjusting items:
Loss (income) from investments, net		996				1,122				(137	)			1,266
Impairments, net		134				—				2,090				818
Loss on extraordinary events		194				—				376				—
Loss on notes receivable		—				1,726				—				1,726
Write down (recovery) of assets held-for-sale		—				—				874				(8,616	)
Equity-based compensation expense		1,655				6,981				5,814				13,023
Legal settlements, net		(310	)			312				(335	)			322
Gain on business divestiture		(292	)			(11,682	)			(296	)			(11,682	)
Other non-recurring expenses		952				2,923				2,278				4,501
Adjusted EBITDA (non-GAAP)*	$	10,385			$	8,086			$	19,012			$	9,681